APA (7th ed.) Citation

Besse, C. E., Winicki, N. M., Puerta, C., Hernandez, M., Yuan, J. X., & Thistlethwaite, P. A. (2024). Delta‐like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials. Pulmonary Circulation, 14(4), 1. https://doi.org/10.1002/pul2.12450

Chicago Style (17th ed.) Citation

Besse, Casandra E., Nolan M. Winicki, Cristian Puerta, Moises Hernandez, Jason X.‐J Yuan, and Patricia A. Thistlethwaite. "Delta‐like Ligand 4 Inhibitor Drug Treatment Induces Pulmonary Hypertension in Cancer Clinical Trials." Pulmonary Circulation 14, no. 4 (2024): 1. https://doi.org/10.1002/pul2.12450.

MLA (9th ed.) Citation

Besse, Casandra E., et al. "Delta‐like Ligand 4 Inhibitor Drug Treatment Induces Pulmonary Hypertension in Cancer Clinical Trials." Pulmonary Circulation, vol. 14, no. 4, 2024, p. 1, https://doi.org/10.1002/pul2.12450.